Moreover, AMPs have been reported to selectively target human tumor cells through their ability to bind the phospholipid phosphatidylserines (PS), which are localized in the outer leaflet of the plasma membrane of cancer cells, leading to necrosis or apoptosis [17]. The gene discussed is ADSL; the disease is cancer.